Pancreatic Cancer Research

ResearcherLund UniversityActive in the last 2 years

Aida Habtezion

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4473-006X; OpenAlex author ID A5019899805; NIH RePORTER profile ID 7931431. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 2)
Trials
0
Grants
2
Labs led
1
Collaborators
65
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 3 papers · 2017: none · 2018: 6 papers · 2019: none · 2020: 1 paper, 1 grant · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 grant

Papers 12

  1. Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. Co-author DOI 10.1016/j.stemcr.2021.04.004↗
  2. Unique circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and w… Last author DOI 10.1016/j.pan.2019.11.008↗
  3. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer. Co-author DOI 10.1016/j.jand.2017.07.005↗
  4. An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice. Co-author DOI 10.1053/j.gastro.2018.08.028↗
  5. The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and D… Co-author DOI 10.1097/mpa.0000000000001037↗
  6. Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rational… Co-author DOI 10.1097/mpa.0000000000001168↗
  7. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the … Co-author DOI 10.1097/mpa.0000000000001170↗
  8. IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-17-3131↗
  9. Macrophages and pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2015.11.049↗
  10. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Co-author DOI 10.1016/s2468-1253(16)30106-6↗
  11. HDAC3 mediates smoking-induced pancreatic cancer. Co-author DOI 10.18632/oncotarget.6820↗
  12. Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma. Last author DOI 10.1053/j.gastro.2012.12.042↗

Grants 2

  1. The Stanford Clinical Center for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer U01DK108300↗
  2. Role of immune cells in chronic pancreatitis R01DK105263↗

Closest collaborators

The 25 strongest of 65 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Walter Gwang-Up Park · 2 shared papers, 1 shared grant, 2018–2024 · strength 0.89
  2. Seung K Kim · 1 shared grant, 2024 · strength 0.72
  3. Stephen Jacob Pandol · 7 shared papers, 2016–2018 · strength 0.47
  4. Dana K. Andersen · 5 shared papers, 2016–2020 · strength 0.36
  5. Dhiraj Yadav · 4 shared papers, 2016–2020 · strength 0.28
  6. Murray Korc · 4 shared papers, 2016–2018 · strength 0.25
  7. Phil A. Hart · 4 shared papers, 2016–2018 · strength 0.25
  8. David Clement Whitcomb · 3 shared papers, 2018–2020 · strength 0.23
  9. Mouad Edderkaoui · 3 shared papers, 2016–2018 · strength 0.21
  10. William E. Fisher · 3 shared papers, 2018 · strength 0.20
  11. Mark Goodarzi · 3 shared papers, 2016–2018 · strength 0.19
  12. Zobeida Cruz‐Monserrate · 3 shared papers, 2016–2018 · strength 0.19
  13. Suresh T. Chari · 3 shared papers, 2016–2018 · strength 0.17
  14. Edgar G. Engleman · 2 shared papers, 2018–2021 · strength 0.17
  15. Jing Xue · 3 shared papers, 2013–2018 · strength 0.17
  16. Steven J. Hughes · 2 shared papers, 2018–2020 · strength 0.17
  17. Guido Eibl · 2 shared papers, 2018 · strength 0.14
  18. Maxim S. Petrov · 2 shared papers, 2018 · strength 0.14
  19. José Serrano · 2 shared papers, 2018 · strength 0.12
  20. Sudhir Srivastava · 2 shared papers, 2018 · strength 0.12
  21. Jo Ann Rinaudo · 2 shared papers, 2018 · strength 0.12
  22. Yogish C. Kudva · 2 shared papers, 2016–2018 · strength 0.11
  23. Melena D. Bellin · 2 shared papers, 2016–2018 · strength 0.11
  24. Christopher E Forsmark · 2 shared papers, 2016–2018 · strength 0.11
  25. Joseph C. Wu · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.